Chargement en cours...
Clinical utility of ramucirumab in non-small-cell lung cancer
Lung cancer is the leading cause of cancer-related mortality worldwide. Non-small-cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases and approximately 70% of patients with NSCLC have locally advanced or metastatic disease at presentation. In NSCLC patients with advanced or meta...
Enregistré dans:
| Publié dans: | Biologics |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659776/ https://ncbi.nlm.nih.gov/pubmed/31413541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S175034 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|